← Evidence map

ArticleFrontiers in medicine2026

Ishak stage 6 fibrosis is more likely to regress than stage 5 in CHB patients undergoing entecavir therapy.

Mengjie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 41877798